Research & Development



可是這時候已經有陣輕盈的腳步聲從樓梯上傳來。來的是伊羅娜。她向 我走來的時候,也像剛才僕人一樣低垂著眼楮。 91视频 “啊,少尉先生,您在這兒等,那實在太好了!”他可真的舒了口氣。 “封?開克斯法爾伐先生呆會兒也要回來了,他一定非常高興歡迎少尉先生。 他剛才特意吩咐我??”免费观看 我連忙搪塞過去︰“沒有的事。我就來。”三腳兩跳,我們就到了樓梯 口,到了那兒我又猛地一下轉過身去。 現在可又輪到她瞠目結舌了。她覺得我的話里還有一層看不透的意思, 她沒法理解。她的眼楮露出煩躁的神色,兩道眉毛擰得越來越緊了。我看出 來,我得把話說得更加露骨一些。91老司机精品视频 “想了整整一個晚上。唉,這是多麼美妙的一天啊,我永遠也不會忘記 這一天。這一路上真是美妙,妙不可言!”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo